Michael Doherty was just 17 when he lost the ability to walk, but the former St. Paul's studenthasn't lost his determination to regain the mobility taken from him when he suffered a spinal cord injury during a 2016 football game at the Covington school.
Now a junior at LSU, Doherty is quick to say that he's gained something in the years since his injurythe realization that nothing should be taken for granted and a deep gratitude for those who've helped him, including doctors, nurses and therapists, as well as family and friends.
During a recent visit to Lakeview Regional Medical Center, the 21-year-old said thank you in person to some of the staff members who cared for him when he arrived at the Covington areahospital's emergency department on that fateful November night, a stay that stretched to 17 days.
Michael Doherty, center, heads to his truck after visiting with the medical team at Lakeview Regional Medical Center near Covington that helped him during surgery and recovery following a spinal injury he suffered while playing high school football in November 2016. Doherty uses a wheelchair to get around but he and his doctors hope he'll be able to walk again in the future. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)
"He could hardly raise his arms," said Holly Leonhard, then a critical care nurse and now a nurse practitioner, as she marveled at her former patient's progress.
This time, Doherty arrived at the hospital on his own steam, driving a modified truck that uses hand controls and a platform that slides out so he can maneuver his wheelchair without assistance.
Many people on his team of caregivers 27 in all had not seen him since he left the hospital four years ago. But they hadn't forgotten his determination to recover, something that they say was evident from the outset.
Sharon Resmondo, who was a night nurse then, choked up a bit as she recalled those days.
"The beginning was very hard," she said. "But he rallied every day."
"I have children his age," critical care nurse Melanie Norris added. "It was his resolve: he was going to get through it. Your heart went out to him. He hasn't proven us wrong yet."
Hospital staffers remember lighter moments, too, particularly the unending stream of visitors, mostly his classmates, and their gentle bending of the rules to allow them to be there for their friend. His hospital room was rearranged to bring in a big-screen TV, and some friends even slept over.
Nurse Practitioner Sharon Resmondo, center, holds up her phone so that other medical staff who couldn't see Michael Doherty in person could visit with him in a video chat on Wednesday, December 9, 2020 at Lakeview Regional Medical Center near Covington. Doherty wanted to thank the medical staff that helped him during surgery and in his recovery following a spinal injury suffered during a high school football game in November 2016. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)
Dr. Marco Hidalgo, medical director of the hospital's trauma program, said there was a train of people bringing food just for the visitors.
"I kept asking, 'Don't these kids have to go to school?' There was never a day when there were not at least a dozen," Hidalgo said. "He had more visitors in a day than the whole hospital has now."
Because of COVID-19, he pointed out, such attention isn't possible.
Doherty, at the time a junior defensive back, was injured in what appeared to be a routine play in a November 2016 playoff game against Archbishop Shaw. But after the play, Doherty couldn't pick himself up.
Michael Doherty, center, is surrounded by some of the medical team that helped him during surgery and recovery at Lakeview Regional Medical Center near Covington back in November 2016 following a spinal injury he suffered at a high school football game. On Wednesday, December 9, 2020, Doherty drove to the hospital using a modified truck to thank the staff. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)
Dr. Justin Owen, a neurosurgeon, got the phone call from the football field that night about an injured player who couldn't feel his legs. While those on the scene were focused on his thoracic spine, Owen said he was much more concerned about his neck, and that is where his spinal cord was compressed, at the C5-6 vertebrae. Doctors were also worried about a possible clot in one of the arteries that supplies blood to the brain.
Owen and the others operated on Doherty deep into the next morning and the plan was to transfer him to New Orleans afterward. But Owen said the south shore hospital "got cold feet." So Lakeview reevaluated him and kept a very close eye on him, he said.
His caregivers agree that the presence of so many people was a key to Doherty's recovery, which wouldn't have been possible if he had been moved. "The fact that he was closer meant that family and friends could be there," Hidalgo said.
Doherty left Lakeview Regional to go the Shepherd Center in Atlanta, where he worked hard at rehabilitation, returning to St. Paul's in March of 2017 to finish his junior year. He has returned to the Shepherd Center since, and also works on his own.
He has some feeling in his legs and has regained enough arm movement to handle a cellphone, cups and the all-important hand controls for his truck.
"It gives me a lot of independence," he said. "I had to rely on other people for rides."
Michael Doherty visits with the medical team that helped him during surgery and recovery at Lakeview Regional Medical Center near Covington on Wednesday, December 9, 2020. In November 2016, Doherty suffered a spinal injury during a high school football game. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)
As for school, he jokingly told Owen, "It's fun, but the school part sucks." He's looking forward to life after college, when he hopes to have a career in sports administration.
His love of football hasn't diminished, and his on-campus job is working in the player personnel office for the LSU football program, which handles recruitment.
"It was a great year last year, then 2020 came," Doherty said with a smile.
But his biggest goal remains to walk again. Owen and Hidalgo believe he will.
"You're going to walk again, I know it's going to happen," Hidalgo told Doherty. The reason, he said, is Doherty's spirit. "I really would not tell that to a lot of patients."
The steering wheel on the modified truck that Michael Doherty drives. Doherty recently visited with the team at Lakeview Regional Medical Center near Covington that helped him during surgery and recovery following a spinal injury he suffered while playing high school football in November 2016. Doherty uses a wheelchair to get around but he and his doctors hope he'll be able to walk again in the future. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)
Owen pointed to advances in research, including stem cell therapy and robotics, and Doherty's youth. Statistically, those most likely to succeed are often athletes, he said, because they understand the demands that must be met to do something like winning a two-minute race.
For Doherty, the race is more of a marathon, but one he intends to win.
He found himself in a reflective mood after watching a football game at his alma mater before Thanksgiving, prompting him to make a rare post on social media. "Four years ago, I played my last football game and my life was forever changed," he wrote. "I miss playing football, and I wish I could play one more game."
But he also stressed the positives in his life. "I want to thank every doctor, nurse and therapist that has helped me along the way," he wrote. "I appreciate everything you had done for me. This journey will not stop until I reach my final goal of walking again."
"I wouldn't be where I am today without them."
Read more from the original source:
Four years after devastating spinal injury, former St. Paul's football player reunites with caregivers - NOLA.com
- The stem cell market was valued at USD 14.7 billion in 2020, and it is expected - GlobeNewswire - June 8th, 2021
- Innovative Regenerative Medicine Therapies Safety Comes First - FDA.gov - June 8th, 2021
- Early Promise of AntiCLL-1 CAR T-Cell Therapy Reported in Pediatric AML - Cancer Network - June 8th, 2021
- Part 3: Moving Forward and Keeping Stem Cell Treatments Safe - MedShadow - June 8th, 2021
- In Some Heavily Pretreated Patients with R/R MM Ide-Cel Continues to Show Deep and Durable Responses - Targeted Oncology - June 8th, 2021
- Innovative research refines the treatment of patients with advanced cancers and the use of immunotherapy - Network News, Press Releases - Hackensack... - June 8th, 2021
- Mustang Bio to Host Key Opinion Leader Webinar on MB-106 CD20-Targeted CAR T for the Treatment of High-Risk B-Cell Non-Hodgkin Lymphomas and Chronic... - June 8th, 2021
- Karen Hasty Named Among 2021 Super Women In Business by Memphis Business Journal - UTHSC News - June 8th, 2021
- High Overall Response Rates Achieved With Cirmtuzumab/Ibrutinib in MCL and CLL - Targeted Oncology - June 8th, 2021
- New Data on KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Versus Sunitinib in First-Line Treatment for Patients With Advanced Renal Cell... - June 8th, 2021
- Chao family gifts to UCI Health for cancer care top $50 million - UCI News - June 8th, 2021
- Sorrento and Researchers at Karolinska Institutet Have Signed a Research Collaboration Agreement on iPSC-Derived Dimeric - GlobeNewswire - June 8th, 2021
- Responses to Tafasitamab/Lenalidomide in DLBCL Sustained at Three Years - Cancer Network - June 8th, 2021
- The regenerative medicine market size to grow at a CAGR of around 30% during the period - GlobeNewswire - June 8th, 2021
- 'Natural Killer Cells' and Other Promising Cancer Treatments - Barron's - April 18th, 2021
- Capturing the Pandemic Experience in Haiku Poetry - Duke Today - April 18th, 2021
- Chemotherapy for Prostate Cancer: When It's Used and What to Expect - Healthline - April 18th, 2021
- Signs that Chemo Is Working: How Effectiveness Is Measured and Defined - Healthline - April 18th, 2021
- Some experts fear next-generation Covid vaccines may be worse - STAT - April 18th, 2021
- How Long is Chemotherapy? What to Expect - Healthline - April 18th, 2021
- Regenerative Medicine - Stem Cell Therapy Little Rock - March 8th, 2021
- Center for Stem Cell Biology & Regenerative Medicine ... - March 8th, 2021
- Dynamic Stem Cell Therapy Offers Regenerative Medicine - Las Vegas Review-Journal - March 8th, 2021
- Anti-EGFR VHH-armed death receptor ligandengineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers -... - March 8th, 2021
- Research Antibodies Market Size to Reach USD 5325.8 Million by 2027 | Increasing R&D Activities in the Fields of Oncology, Neurobiology, and Stem... - March 8th, 2021
- Microwave Processing Isolates Red Ginseng Compounds That Suppress Lung Cancer Metastasis - Genetic Engineering & Biotechnology News - March 8th, 2021
- Longeveron Expands Enrollment Criteria for its Phase 1 RECOVER Trial Evaluating Lomecel-B Infusion to Treat Acute Respiratory Distress Syndrome due to... - March 8th, 2021
- Be The Match BioTherapies Announces Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics to Support European Commercial Launch of... - March 8th, 2021
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2021: Focuses at the key worldwide companies to Define, Describe and Analyses the sales... - March 8th, 2021
- Editing Reproduction: CRISPR and preventing heritable diseases, With Dr. Dietrich Egli and Dr. Sam Sternberg - Columbia University Irving Medical... - March 8th, 2021
- U. Cancer Center pilot projects: investigating cancer connections - The Brown Daily Herald - March 8th, 2021
- COVID-19 can kill heart muscle cells, interfere with contraction Washington University School of Medicine in St. Louis - Washington University School... - March 8th, 2021
- Vaccinating by age groups is unfair, particularly to minorities, advisory panel tells CDC - USA TODAY - March 8th, 2021
- Winter Weather Impacting Blood and Platelet Donations - Milwaukee Community Journal - February 17th, 2021
- Joshua Shirk continues to fight the odds; mom says God placed people where they needed to be to help him - Keyser Mineral Daily News Tribune - February 17th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure - GuruFocus.com - February 7th, 2021
- ProgenCell - Stem Cell Therapies offers an updated Stem Cell Therapy for Anti Aging Protocol - PR Web - January 30th, 2021
- Doctors urge immunocompromised to get COVID vaccine when it becomes available - KMTV - 3 News Now - January 30th, 2021
- Autologous Stem Cell and Non Stem Based therapies Market Share, Size 2021 Global Industry Future Trends, Growth, Strategies,, Segmentation, In-depth... - January 30th, 2021
- Studies Indicating T-Cells May Be Needed For Long-Term Protection From The SARS-Cov-2 Virus - PRNewswire - January 30th, 2021
- Researchers use patients' cells to test gene therapy for rare eye disease - National Institutes of Health - January 30th, 2021
- Two Gene Therapies Fix Fault in Sickle Cell Disease and -thalassemia - MD Magazine - January 30th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 30th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 30th, 2021
- Profile of T Cells, Broadly Neutralizing Antibodies, Anti-Viral Targets: COVID-19 Updates - Bio-IT World - January 30th, 2021
- HealthLynked's The Future of Healthcare Summit Brings Healthcare Experts and Technology Innovators from Around the World to Naples, Florida - WFMZ... - January 30th, 2021
- Tevogen Bio Secures Funding from Team of Doctors to Support Clinical Trials of Its Investigational Curative T Cell Therapy for COVID-19 - PRNewswire - January 25th, 2021
- Novel Treatment Leads to Dog's Recovery - The Bark - January 25th, 2021
- Identification and Targeting of ThomsenFriedenreich and IL1RAP | OTT - Dove Medical Press - January 25th, 2021
- Regenerative Medicine Market Size Worth $74831.35 Million With CAGR of 22.27% By 2024 | Segmented by Product Type, Top Manufacturers, By End-User... - January 25th, 2021
- Immunotherapy Inches Forward in Development of Myeloid Malignancies - OncLive - January 14th, 2021
- Cytovia Therapeutics Partners with National Cancer Institute to Develop Novel Gene-Edited, iPSC-Derived GPC3 CAR NK Cells for the Treatment of Solid... - January 14th, 2021
- Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19 - BioSpace - January 14th, 2021
- Doctors Make Medical Breakthrough In Treating Severe Cases Of COVID - CBS San Francisco - January 9th, 2021
- Mana joins the hectic fight against solid tumors with an 'off-the-shelf' candidate angling for an IND this year - Endpoints News - January 9th, 2021
- Versiti Blood Centers and Noodles & Company Serve Up Thanks to Blood Donors - PRNewswire - December 31st, 2020
- Global CAR-T Pipeline Insight Report 2020: Overview, Landscape, Therapeutic Assessment, Current Treatment Scenario and Emerging Therapies -... - December 31st, 2020
- 2020 health care year in review - Crain's Cleveland Business - December 31st, 2020
- The Top 10 FDA Oncology Drug Approvals of 2020 - Curetoday.com - December 31st, 2020
- Gut microbiota: How does it interact with the brain? - Medical News Today - December 31st, 2020
- Numerous Indian American STEM Researchers Named Fellows of American Association for the Advancement of Sciences - India West - December 31st, 2020
- New Combination Therapy Tested By Children's May Offer Hope For Leukemia Patients - WVXU - December 24th, 2020
- Real-time observation helpful in Stem cell for vascular diseases: Study - Hindustan Times - December 21st, 2020
- NurOwn May Be Given to Early ALS Patients in US Who Finished Phase... - ALS News Today - December 21st, 2020
- Follow the Money: Spatial Omics, CAR-NK Cells, AI-Powered Biology - Bio-IT World - December 21st, 2020
- Explained: Process of transporting stem cell from donor to patient for a successful transplant - Firstpost - December 18th, 2020
- Research That Saves Lives: Four COVID-19 Therapies Being Tested at UVA - University of Virginia - December 18th, 2020
- Even if You've Had COVID-19 You Still Need the Vaccine - Healthline - December 18th, 2020
- What Patients With Cancer, Survivors Need to Know About the Emergency Use Authorization of COVID-19 Vaccine - Curetoday.com - December 16th, 2020
- 2020 at the U: The year in review - University of Miami - December 16th, 2020
- Five Mobile County hospitals to get Pfizer vaccine this week - AL.com - December 16th, 2020
- Donor Stem Cell Transplant Improves Survival in Older Patients with Myelodysplastic Syndrome - Cancer Health Treatment News - December 10th, 2020
- Positive Phase 2 Proof-of-Concept Data for Viralym-M and Burden of Disease Data Presented in Oral Presentations at the 62nd American Society of... - December 10th, 2020
- Dr. Kansagra: Quadruplet Therapy for Newly Diagnosed Multiple Myeloma and Combination CAR T-Cell Opportunities - DocWire News - December 10th, 2020
- Silicon Therapeutics Announces Members of Scientific Advisory Board - Business Wire - December 10th, 2020
- Israeli Neurogenesis' NG-01 slows progressive MS by up to 90% in phase II study - BioWorld Online - December 10th, 2020
- ADC Therapeutics Announces Updated Clinical Data on Lead Antibody Drug Conjugate Programs Loncastuximab Tesirine (Lonca) and Camidanlumab Tesirine... - December 10th, 2020
- Magenta Therapeutics Announces Commencement of First Phase 2 Clinical Trial of MGTA-145 for Stem Cell Mobilization, Oral Presentation of MGTA-145... - December 8th, 2020
- Precigen Presents New Data Supporting the Safety, Clinical Activity, Expansion and Persistence of PRGN-3006 UltraCAR-T at the 62nd ASH Annual Meeting... - December 8th, 2020
- ALLO-715, Off-the-Shelf CAR T-Cell Therapy, Produces Early Promise in Multiple Myeloma - Cancer Network - December 8th, 2020